Commentary

TikTok’s fave weight loss drugs: Link to thyroid cancer?


 

How to advise our patients and respond to the EMR messages

The TikTok videos may continue, the celebrity chatter may increase, and we, as physicians, will continue to look to real-world data with randomized controlled trials to tailor our decision-making and guide our patients.

It’s prudent to advise patients that if they have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2, in particular, they should avoid using this class of medication. Thyroid cancer remains a rare outcome, and GLP-1 receptor agonists remain a very important and beneficial treatment option for the right patient.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Urine screen as part of triple test improves ID of adrenal cancer
AVAHO
Adding liothyronine for hypothyroidism doesn’t up breast cancer risk
AVAHO
Cancer-related thyroidectomy linked to increased diabetes risk
AVAHO
Nedaplatin chemo proves to be a less toxic option for nasopharyngeal carcinoma
AVAHO
Radiofrequency ablation an option for thyroid microcarcinoma
AVAHO
Radioactive iodine shows no benefit in low-risk thyroid cancer
AVAHO
No link between cell phones and brain tumors in large U.K. study
AVAHO
Thyroid autoimmunity linked to cancer, but screening not advised
AVAHO
Lifestyle choices could curb genetic risk for thyroid cancer
AVAHO
Taking a break from TKIs unlikely to shorten survival
AVAHO